Repository logo
 

Onset of Effect and Impact on Health-Related Quality of Life, Exacerbation Rate, Lung Function, and Nasal Polyposis Symptoms for Patients with Severe Eosinophilic Asthma Treated with Benralizumab (ANDHI): a Randomised, Controlled, Phase 3b Trial

Simple item page
dc.contributor.authorMohan, Arjun
dc.contributor.authorHarrison, Tim
dc.contributor.authorChanez, Pascal
dc.contributor.authorMenzella, Francesco
dc.contributor.authorCanonica, Giorgio Walter
dc.contributor.authorLouis, Renaud
dc.contributor.authorCosio, Borja
dc.contributor.authorLugogo, Njira
dc.contributor.authorBurden, Annie
dc.contributor.authorMcdermott, Lawrence
dc.date.accessioned2022-10-14T18:59:19Z
dc.date.available2022-10-14T18:59:19Z
dc.date.issued2021
dc.identifier.urihttp://hdl.handle.net/10342/11522
dc.language.isoen_USen_US
dc.subjecteosinophilic asthmaen_US
dc.subjectbenralizumaben_US
dc.subjectlung functionen_US
dc.titleOnset of Effect and Impact on Health-Related Quality of Life, Exacerbation Rate, Lung Function, and Nasal Polyposis Symptoms for Patients with Severe Eosinophilic Asthma Treated with Benralizumab (ANDHI): a Randomised, Controlled, Phase 3b Trialen_US
dc.typeArticleen_US
ecu.journal.issue3en_US
ecu.journal.nameThe Lancet Respiratory Medicineen_US
ecu.journal.pages260-274en_US
ecu.journal.volume9en_US

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
MohanOnsetofEffectandImpactonHealthRelatedQualityofLifeExacerbationRateLungFunction.pdf
Size:
58.25 MB
Format:
Adobe Portable Document Format
Description:
Download

Collections

Pulmonary , Critical Care, and Sleep Medicine